7th Jan 2008 12:55
GW Pharmaceuticals PLC07 January 2008 GW Pharmaceuticals plc Notification of Results Porton Down, UK, 7 January 2008: GW Pharmaceuticals plc (AIM: GWP) will beannouncing its preliminary results for the year ended 30 September 2007 onTuesday 22 January 2008. Enquiries: Financial Dynamics 020 7831 3113Gemma Cross Brown Notes to Editors About GW Pharmaceuticals plc GW was founded in 1998 and listed on the AiM, a market of the London StockExchange, in June 2001. Operating under license from the UK Home Office, thecompany researches and develops cannabinoid pharmaceutical products thatalleviate pain and other neurological symptoms in patients who suffer fromserious ailments. GW has assembled a team of over 100 scientists with extensiveexperience in developing both plant-based prescription pharmaceutical productsand medicines containing controlled substances. GW occupies a world leadingposition in cannabinoids and has developed an extensive international network ofthe most prominent scientists in the field. For further information, pleasevisit www.gwpharm.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
GWP.L